Cargando…
Emerging strategies for treating metastasis
The systemic spread of tumor cells is the ultimate cause of the majority of deaths from cancer, yet few successful therapeutic strategies have emerged to specifically target metastasis. Here we discuss recent advances in our understanding of tumor-intrinsic pathways driving metastatic colonization a...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064405/ https://www.ncbi.nlm.nih.gov/pubmed/33899000 http://dx.doi.org/10.1038/s43018-021-00181-0 |
_version_ | 1783682128241754112 |
---|---|
author | Esposito, Mark Ganesan, Shridar Kang, Yibin |
author_facet | Esposito, Mark Ganesan, Shridar Kang, Yibin |
author_sort | Esposito, Mark |
collection | PubMed |
description | The systemic spread of tumor cells is the ultimate cause of the majority of deaths from cancer, yet few successful therapeutic strategies have emerged to specifically target metastasis. Here we discuss recent advances in our understanding of tumor-intrinsic pathways driving metastatic colonization and therapeutic resistance, as well as immune activating strategies to target metastatic disease. We focus on therapeutically exploitable mechanisms, promising strategies in preclinical and clinical development, and emerging areas with potential to become innovative treatments. |
format | Online Article Text |
id | pubmed-8064405 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-80644052021-09-01 Emerging strategies for treating metastasis Esposito, Mark Ganesan, Shridar Kang, Yibin Nat Cancer Article The systemic spread of tumor cells is the ultimate cause of the majority of deaths from cancer, yet few successful therapeutic strategies have emerged to specifically target metastasis. Here we discuss recent advances in our understanding of tumor-intrinsic pathways driving metastatic colonization and therapeutic resistance, as well as immune activating strategies to target metastatic disease. We focus on therapeutically exploitable mechanisms, promising strategies in preclinical and clinical development, and emerging areas with potential to become innovative treatments. 2021-03-24 2021-03 /pmc/articles/PMC8064405/ /pubmed/33899000 http://dx.doi.org/10.1038/s43018-021-00181-0 Text en http://www.nature.com/authors/editorial_policies/license.html#termsUsers may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Esposito, Mark Ganesan, Shridar Kang, Yibin Emerging strategies for treating metastasis |
title | Emerging strategies for treating metastasis |
title_full | Emerging strategies for treating metastasis |
title_fullStr | Emerging strategies for treating metastasis |
title_full_unstemmed | Emerging strategies for treating metastasis |
title_short | Emerging strategies for treating metastasis |
title_sort | emerging strategies for treating metastasis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064405/ https://www.ncbi.nlm.nih.gov/pubmed/33899000 http://dx.doi.org/10.1038/s43018-021-00181-0 |
work_keys_str_mv | AT espositomark emergingstrategiesfortreatingmetastasis AT ganesanshridar emergingstrategiesfortreatingmetastasis AT kangyibin emergingstrategiesfortreatingmetastasis |